Moderna’s covid jab more likely to trigger myocarditis than Pfizer’s

‘Moderna's Covid vaccine should be made available for children aged six to 17 years, an independent panel at the Food and Drug Administration said Tuesday — as America's Covid wave fell on all fronts.

All 22 members of the panel convened by the FDA voted to approve the two-dose jab for the age group following an all-day debate on the issue.

It comes after the CDC released an analysis today suggesting the Moderna jab was more likely to trigger heart inflammation in young and middle-aged men than its Pfizer competitor.

In a separate release today the CDC said among men aged 18 to 39 who received two doses of Moderna's Covid shot, about 97.3 cases per million shots given out had myocarditis or pericarditis recorded.

For comparison, with the Pfizer shot these cases were recorded at a rate of 81.7.

Scientists are still unsure why the vaccines — which use the same mRNA technology — trigger the condition, although it may be linked to an immune response to a vaccine. ‘

[link to www.dailymail.co.uk (secure)]

Vaccines and Related Biological Products Advisory Committee Meeting June 14-15, 2022
FDA Briefing Document

[link to www.fda.gov (secure)]